CLX
Get informed when a big investor buys or sells
+ FollowOctober 30, 2024 - AI Summary
Undervalued by 110.7% based on the discounted cash flow analysis.
| Market cap | $12.90 Billion |
|---|---|
| Enterprise Value | $18.28 Billion |
| Dividend Yield | $4.96 (4.66%) |
| Earnings per Share | $4.82 |
| Beta | 0.54 |
| Outstanding Shares | 121,775,000 |
| P/E Ratio | 22.13 |
|---|---|
| PEG | -43.48 |
| Price to Sales | 1.92 |
| Price to Book Ratio | 52.78 |
| Enterprise Value to Revenue | 2.72 |
| Enterprise Value to EBIT | 19.59 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.3 |
| Debt to Equity | 61.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7571▲ 7.94% |
|---|---|
| Total Calls | 4,051,200▲ 59.34% |
| Total Puts | 3,067,225▲ 78.02% |
Holdings and activity of institutional investors.
| Ownership % | 86.36%▲ 4.33% |
|---|---|
| Total Invested | $9.99B▼ 2.96% |
| Investors Holding | 1,064▼ 59.00% |
No data
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...